Literature DB >> 1533222

Characterization of the endomannosidase pathway for the processing of N-linked oligosaccharides in glucosidase II-deficient and parent mouse lymphoma cells.

S E Moore1, R G Spiro.   

Abstract

Studies on N-linked oligosaccharide processing in the mouse lymphoma glucosidase II-deficient mutant cell line (PHAR2.7) as well as the parent BW5147 cells indicated that the former maintain their capacity to synthesize complex carbohydrate units through the use of the deglucosylation mechanism provided by endomannosidase. The in vivo activity of this enzyme was evident in the mutant cells from their production of substantial amounts of glucosylated mannose saccharides, predominantly Glc2Man; moreover, in the presence of 1-deoxymannojirimycin or kifunensine to prevent processing by mannosidase I, N-linked Man8GlcNAc2 was observed entirely in the form of the characteristic isomer in which the terminal mannose of the alpha 1,3-linked branch is missing (isomer A). In contrast, parent lymphoma cells, as well as HepG2 cells in the presence of 1-deoxymannojirimycin accumulated Man9GlcNAc2 as the primary deglucosylated N-linked oligosaccharide and contained only about 16% of their Man8GlcNAc2 as isomer A. In the presence of the glucosidase inhibitor castanospermine the mutant released Glc3Man instead of Glc2Man, and the parent cells converted their deglucosylation machinery to the endomannosidase route. Despite the mutant's capacity to accommodate a large traffic through this pathway no increase in the in vitro determined endomannosidase activity was evident. The exclusive utilization of endomannosidase by the mutant for the deglucosylation of its predominant N-linked Glc2Man9GlcNAc2 permitted an exploration of the in vivo site of this enzyme's action. Pulse-chase studies utilizing sucrose-D2O density gradient centrifugation indicated that the Glc2Man9GlcNAc2 to Man8GlcNAc2 conversion is a relatively late event that is temporally separated from the endoplasmic reticulum-situated processing of Glc3Man9GlcNAc2 to Glc2Man9GlcNAc2 and in contrast to the latter takes place in the Golgi compartment.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1533222

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Golgi apparatus immunolocalization of endomannosidase suggests post-endoplasmic reticulum glucose trimming: implications for quality control.

Authors:  C Zuber; M J Spiro; B Guhl; R G Spiro; J Roth
Journal:  Mol Biol Cell       Date:  2000-12       Impact factor: 4.138

2.  Processing alpha-glucosidase I is an inverting glycosidase.

Authors:  M M Palcic; C H Scaman; A Otter; A Szpacenko; A Romaniouk; Y X Li; I K Vijay
Journal:  Glycoconj J       Date:  1999-07       Impact factor: 2.916

3.  Cellular effects of deoxynojirimycin analogues: inhibition of N-linked oligosaccharide processing and generation of free glucosylated oligosaccharides.

Authors:  Howard R Mellor; David C A Neville; David J Harvey; Frances M Platt; Raymond A Dwek; Terry D Butters
Journal:  Biochem J       Date:  2004-08-01       Impact factor: 3.857

4.  The molecular chaperone calnexin facilitates folding and assembly of class I histocompatibility molecules.

Authors:  A Vassilakos; M F Cohen-Doyle; P A Peterson; M R Jackson; D B Williams
Journal:  EMBO J       Date:  1996-04-01       Impact factor: 11.598

5.  Structural and mechanistic insight into N-glycan processing by endo-α-mannosidase.

Authors:  Andrew J Thompson; Rohan J Williams; Zalihe Hakki; Dominic S Alonzi; Tom Wennekes; Tracey M Gloster; Kriangsak Songsrirote; Jane E Thomas-Oates; Tanja M Wrodnigg; Josef Spreitz; Arnold E Stütz; Terry D Butters; Spencer J Williams; Gideon J Davies
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-04       Impact factor: 11.205

6.  Glycoprotein structural genomics: solving the glycosylation problem.

Authors:  Veronica T Chang; Max Crispin; A Radu Aricescu; David J Harvey; Joanne E Nettleship; Janet A Fennelly; Chao Yu; Kent S Boles; Edward J Evans; David I Stuart; Raymond A Dwek; E Yvonne Jones; Raymond J Owens; Simon J Davis
Journal:  Structure       Date:  2007-03       Impact factor: 5.006

7.  Cell type-dependent variations in the subcellular distribution of alpha-mannosidase I and II.

Authors:  A Velasco; L Hendricks; K W Moremen; D R Tulsiani; O Touster; M G Farquhar
Journal:  J Cell Biol       Date:  1993-07       Impact factor: 10.539

8.  Structural Analysis of Free N-Glycans in α-Glucosidase Mutants of Saccharomyces cerevisiae: Lack of the Evidence for the Occurrence of Catabolic α-Glucosidase Acting on the N-Glycans.

Authors:  Tanim Jabid Hossain; Yoichiro Harada; Hiroto Hirayama; Haruna Tomotake; Akira Seko; Tadashi Suzuki
Journal:  PLoS One       Date:  2016-03-24       Impact factor: 3.240

9.  Contribution of Shape and Charge to the Inhibition of a Family GH99 endo-α-1,2-Mannanase.

Authors:  Marija Petricevic; Lukasz F Sobala; Pearl Z Fernandes; Lluís Raich; Andrew J Thompson; Ganeko Bernardo-Seisdedos; Oscar Millet; Sha Zhu; Matthieu Sollogoub; Jesús Jiménez-Barbero; Carme Rovira; Gideon J Davies; Spencer J Williams
Journal:  J Am Chem Soc       Date:  2017-01-17       Impact factor: 15.419

Review 10.  Protein quality control: the who's who, the where's and therapeutic escapes.

Authors:  Jürgen Roth; Gary Hin-Fai Yam; Jingyu Fan; Kiyoko Hirano; Katarina Gaplovska-Kysela; Valerie Le Fourn; Bruno Guhl; Roger Santimaria; Tania Torossi; Martin Ziak; Christian Zuber
Journal:  Histochem Cell Biol       Date:  2007-12-13       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.